title: Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials.
authors.affiliation: Department of Medical Sciences, Cardiology and Uppsala Clinical Researwwwch Center, Uppsala University, Dag Hammarskjölds väg 14B, SE-752 37 Uppsala, Sweden. Stefan.James@ucr.uu.se
authors.forename: Stefan K
authors.initials: SK
authors.lastname: James
authors.forename: Karen S
authors.initials: KS
authors.lastname: Pieper
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Cannon
authors.forename: Robert F
authors.initials: RF
authors.lastname: Storey
authors.forename: Richard C
authors.initials: RC
authors.lastname: Becker
authors.forename: Philippe Gabriel
authors.initials: PG
authors.lastname: Steg
authors.forename: Lars
authors.initials: L
authors.lastname: Wallentin
authors.forename: Robert A
authors.initials: RA
authors.lastname: Harrington
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy*; D013927:Thrombosis / Q000188:drug therapy*; D000077486:Ticagrelor; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000077144:Clopidogrel; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine